Eleje George Uchenna, Ugwu Emmanuel Onyebuchi, Igbodike Emeka Philip, Malachy Divinefavour Echezona, Nwankwo Ekeuda Uchenna, Ugboaja Joseph Odirichukwu, Ikechebelu Joseph Ifeanyichukwu, Nwagha Uchenna Ifeanyi
Effective Care Research Unit, Department of Obstetrics and Gynaecology, Nnamdi Azikiwe University, Nnewi, Nigeria.
Institute of Maternal and Child Health, College of Medicine, University of Nigeria Ituku-Ozalla Campus, Enugu, Nigeria.
Front Reprod Health. 2023 Feb 21;5:1049711. doi: 10.3389/frph.2023.1049711. eCollection 2023.
In low-and middle-income countries, no conclusive research explains the prevalence and associated factors of women with a history of recurrent pregnancy loss (RPL). Some authorities have recommended further scientific research on the effect of various definitions of RPL.
To assess prevalence and associated factors of RPL among pregnant women in Nigeria according to different national and international criteria: the American Society for Reproductive Medicine/ European Society for Human Reproduction and Embryology (ASRM/ESHRE; two losses) and the World Health Organization/ Royal College of Obstetricians and Gynecologists (WHO/RCOG; three consecutive losses) criteria.
This is a cross-sectional analytical study wherein, pregnant women with prior RPL were investigated. The outcome measures were prevalence and risk factors. The associations between independent variables and outcome variable were explored using bivariate and multivariable logistic regression models. The results of these analyses were reported as adjusted odds ratios (AORs) with 95% confidence intervals (95%CI). Factors associated with RPL were identified using multivariate regression models.
Of the 378 pregnant women interviewed, the overall prevalence of RPL in this study was found to be 15.34% (95% confidence interval = 11.65%-19.84%). The prevalence of RPL was 15.34% (58/378; 95%CI = 11.65%-19.84%) and 5.29% (20/378; 95%CI = 3.23%-8.17) according to the ASRM and the WHO criterion respectively. Regardless of diagnostic criteria, unexplained (AOR = 23.04; 95%CI: 11.46-36.32), endocrine disturbances (AOR = 9.76; 95%CI: 1.61-63.19), uterine abnormalities (AOR = 13.57; 95%CI: 3.54-50.60), and antiphospholipid syndrome (AOR = 24.59; 95%CI: 8.45-71.04) were positively and independently associated with RPL. No significant risk factors were seen when the ASRM/ ESHRE criterion vs. WHO/RCOG criterion were compared. Advanced maternal age was significantly higher in secondary than in primary type of RPL.
The prevalence of RPL was 15.34% and 5.29% according to ASRM/ESHRE and WHO/RCOG criterion respectively, with secondary type predominating. No significant differences with regard to risk factors were seen according to diagnostic criteria studied, though advanced maternal age was significantly higher in secondary RPL. Further research is needed to confirm our findings and to better characterize the magnitude of differences.
在低收入和中等收入国家,尚无确凿研究能够解释有复发性流产(RPL)病史女性的患病率及相关因素。一些权威机构建议进一步开展科学研究,以探讨RPL不同定义的影响。
根据不同的国内和国际标准,即美国生殖医学学会/欧洲人类生殖与胚胎学会(ASRM/ESHRE;两次流产)以及世界卫生组织/皇家妇产科学院(WHO/RCOG;连续三次流产)标准,评估尼日利亚孕妇中RPL的患病率及相关因素。
这是一项横断面分析研究,对既往有RPL的孕妇进行调查。结局指标为患病率和危险因素。使用二元和多变量逻辑回归模型探讨自变量与结局变量之间的关联。这些分析结果以调整优势比(AOR)及95%置信区间(95%CI)的形式报告。采用多变量回归模型确定与RPL相关的因素。
在接受访谈的378名孕妇中,本研究中RPL的总体患病率为15.34%(95%置信区间=11.65%-19.84%)。根据ASRM和WHO标准,RPL的患病率分别为15.34%(58/378;95%CI=11.65%-19.84%)和5.29%(20/378;95%CI=3.23%-8.17)。无论诊断标准如何,原因不明(AOR=23.04;95%CI:11.46-36.32)、内分泌紊乱(AOR=9.76;95%CI:1.61-63.19)、子宫异常(AOR=13.57;95%CI:3.54-50.60)以及抗磷脂综合征(AOR=24.59;95%CI:8.45-71.04)均与RPL呈正相关且具有独立性。比较ASRM/ESHRE标准与WHO/RCOG标准时,未发现显著的危险因素。继发性RPL的孕妇高龄产妇比例显著高于原发性RPL。
根据ASRM/ESHRE和WHO/RCOG标准,RPL的患病率分别为15.34%和5.29%,以继发性为主。尽管继发性RPL的孕妇高龄产妇比例显著更高,但根据所研究的诊断标准,在危险因素方面未发现显著差异。需要进一步研究以证实我们的发现,并更好地描述差异的程度。